Skip to content
Corner Career Eindhoven

Zimbabwe Turns Down ‘One-Sided’ US Healthcare Assistance Deal Over Data Fears

Medical funding illustration
The proposed US funding was intended for programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

The nation of Zimbabwe has rejected a significant US healthcare agreement worth $367m (£272m) over five years because of Washington's insistence on sensitive information.

This move was revealed after a government memo dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".

A government spokesperson has since stated that the US was seeking genetic material for research and profit but refused to guarantee the resulting advantages from future vaccines.

"We are forced to start the challenging and unfortunate process of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the United States had donated more than $1.9bn as health assistance to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has called for more dialogue to reach a deal agreeable to both sides so the country's vital HIV programme can be sustained.

Broader Context

This rejection follows a similar situation in neighbouring Kenya, where a court blocked a related deal with the US after legal challenges were raised about the safety of citizens' medical information.

After resuming office recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).

The agency had administered aid for the US government, but Trump argued its spending was "inefficient" and his administration was pursuing direct bilateral agreements to boost openness and responsibility.

Based on reports, 16 African countries have so far agreed to similar agreements, representing over $18.3bn in new funding.

Details of the Rejected Deal

The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this cooperation would have delivered significant advantages for the people of Zimbabwe, especially the 1.2 million presently receiving HIV treatment via US-supported initiatives," the Ambassador said.

However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".

"Zimbabwe was being asked to surrender its genetic material and health information for a long time, without any corresponding promise of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," Mangwana explained.

"Effectively, our country would supply the raw materials for medical research with no certainty that the resulting innovations would be available to our citizens should a future health crisis arise."

National Interest and International Frameworks

He also said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending systems previously established via the global health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing framework created to manage future pandemics.

"This mechanism is intended to guarantee that when a country contributes its samples, the benefits – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to develop them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We are open to ongoing dialogue with our American counterparts on how subsequent co-operation could be arranged in a manner that honours the independence and dignity of both nations."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but urged that negotiations need to persist considering a large portion of the country's HIV programmes were funded by international support.

"Where specific concerns arise, including those relating to data governance or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," it commented.

This impasse underscores the ongoing tensions between accepting crucial international aid and protecting a country's data in an ever more data-driven world.

The writer

Michelle Mcmillan

Career coach with 10+ years of experience in helping professionals find their dream jobs.

Corner Career Eindhoven

Type to search articles.